AI
OpenAI and the FDA are reportedly discussing AI for drug evaluations
[ad_1]
OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday.
[ad_2]
Source link
You must be logged in to post a comment Login